These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6183198)

  • 1. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
    Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
    Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of non-HLA-DR determinants by alloreactive lymphocyte clones.
    Zeevi A; Annen K; Scheffel C; Duquesnoy RJ
    Hum Immunol; 1983 Feb; 6(2):97-109. PubMed ID: 6187720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete PLT clones detecting HLA-D and new HLA-non-D encoded cell surface determinants.
    Pawelec G; Kahle P; Müller C; Rehbein A; Wernet P
    Tissue Antigens; 1982 Apr; 19(4):269-88. PubMed ID: 6179257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-D-DR relationships: PLT studies of HLA-D specificities associated with DR1, DR2, and DR4.
    Suciu-Foca N; Godfrey M; Khan R
    Hum Immunol; 1981 Jul; 2(4):295-304. PubMed ID: 6168618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic analysis of the HLA complex with alloreactive T cell clones.
    Duquesnoy RJ; Zeevi A
    Hum Immunol; 1983 Sep; 8(1):17-23. PubMed ID: 6226628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones.
    Zeevi A; Annen K; Scheffel C; Duquesnoy RJ
    Immunogenetics; 1983; 18(3):205-20. PubMed ID: 6604694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells.
    Shaut DM; Ireland J; Scornik JC; Peck AB
    Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class-II HLA restriction of antigen-specific human T-lymphocyte clones. Evidence of restriction elements on both DR and MT molecules.
    Qvigstad E; Thorsby E
    Scand J Immunol; 1983 Oct; 18(4):299-306. PubMed ID: 6196836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis.
    Goronzy J; Weyand CM; Fathman CG
    J Clin Invest; 1986 Mar; 77(3):1042-9. PubMed ID: 2419361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
    Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
    Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis.
    Duquesnoy RJ; Marrari M; Hackbarth S; Zeevi A
    Hum Immunol; 1984 Jul; 10(3):165-76. PubMed ID: 6204958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4.
    Ikeda H; Kasahara M; Ogasawara K; Takenouchi T; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1984; 19(5):381-90. PubMed ID: 6202628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human influenza virus-specific T helper cell clones can be restricted by MHC products different from serologically defined HLA-DR antigens.
    Fleischer B
    Tissue Antigens; 1983 Mar; 21(3):238-45. PubMed ID: 6190261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB.
    Termijtelen A; van den Berge SJ; van Rood JJ
    Hum Immunol; 1983 Sep; 8(1):11-5. PubMed ID: 6195131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new HLA-DRw6- and 8- associated HLA-Dw HAG specificity defined by homozygous typing cell 9W 1802. Analysis with primed lymphocyte typing clones.
    Pawelec G; Müller C; Rehbein A; Balko I; Schunter F; Wernet P
    Tissue Antigens; 1984 Nov; 24(5):292-301. PubMed ID: 6085195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong lymphoproliferative suppressive function of PLT clones specific for SB-like antigens.
    Pawelec G; Wernet P; Rosenlund R; Blaurock M; Schneider EM
    Hum Immunol; 1984 Mar; 9(3):145-57. PubMed ID: 6199336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous typing cell-defined HLA-Dw specificities correlate better than serologically defined HLA-DR specificities with restriction elements for influenza virus-specific proliferative human T lymphocyte clones.
    Fleischer B; Pawelec G; Wernet P
    Hum Immunol; 1985 Sep; 14(1):37-47. PubMed ID: 2411701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typing for human alloantigens with the primed lymphocyte typing technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Adv Immunol; 1982; 32():65-156. PubMed ID: 6180612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.